What if millions of people could lead a better life?
CHALLENGE | Psoriasis
Psoriasis is a serious, chronic skin disease that means physical and social discomfort for people. Untreated, the psoriasis disease could lead to isolation, emotional problems and, at worst, a shorter life.
More than 100 million people worldwide have psoriasis. Only half of these patients receive proper treatment. This is not acceptable. Therefore, we see the challenges faced by people with psoriasis as our challenges.To find out how you can have a better life with psoriasis – see www.psorinfo.com.
New Image Brochure 2008 Read more about the basics of LEO Pharma and download various informational material available.
Read more
FDA Approves Taclonex Scalp® - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis. Warner Chilcott and LEO Pharma announced 12 May that the FDA has approved...
Read more
1-4-2008 - LEO Pharma achieved a fine result in 2007 Psoriasis is a chronic skin disease, which seriously affects the patients’ quality of life and their psychological and physical well-being.Read More
3-1-2008 - New CEO at LEO Pharma A/S LEO Pharma A/S gets a new CEO with effect as from 1 January 2008 when Gitte Aabo, as part of a planned succession, succeeds Ernst Lunding as CEO.Read More
What if millions of people could lead a better life?
News
